| Financial Year |
March 31 2023 |
| Monetary Funds |
3,887,901,369.33 |
| Held-for-trading Financial Assets |
17,123,000.00 |
| Notes Receivable |
156,942,408.27 |
| Accounts Receivable |
1,269,263,902.03 |
| Advances to Suppliers |
78,495,232.80 |
| Other Receivables |
51,088,689.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,566,065,413.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
143,176,230.32 |
| Total Current Assets |
7,253,047,182.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
103,939,374.26 |
| Investment Properties |
12,915,720.60 |
| Fixed Assetes |
3,368,467,281.69 |
| Under-construction Projects |
428,769,435.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
919,116,654.76 |
| R&D expenses |
13,490,565.64 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
47,232,055.86 |
| Deferred Income Tax Assets |
91,600,632.06 |
| Other Non-Current Assets |
179,994,638.08 |
| Sub-Total of Non-Current Assets |
5,201,291,210.41 |
| Total Assets |
12,454,338,393.33 |
| Short-Term Loans |
249,100,804.88 |
| Trading Financial liabilities |
7,742,000.00 |
| Notes Payable |
1,959,006,537.91 |
| Accounts Payable |
1,081,288,247.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
235,735,326.33 |
| Taxes Payable |
103,171,845.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
387,106,406.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
37,186,780.67 |
| Other Current Liabilities |
58,173,816.45 |
| Sub-Total of Current Liabilities |
4,424,667,988.35 |
| Long-term Loans |
684,571,353.25 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,879,615.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
752,188,982.32 |
| Total Liabilities |
5,176,856,970.67 |
| Paid-In Capital(Or Share Stock) |
826,727,780.00 |
| Capital Surplus |
1,986,231,661.13 |
| Surplus Reserve |
469,458,725.66 |
| LESS:Treasury Stock |
81,934,288.92 |
| Undistributed Profits |
3,915,611,709.56 |
| Minority Stockholder's Interest |
143,896,495.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,133,584,926.98 |
| Owner's Equity（Stockholder's Equity） |
7,277,481,422.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,454,338,393.33 |
